Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Share-based Compensation (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Share-based Compensation for 16 consecutive years, with $23.0 million as the latest value for Q1 2026.

  • For Q1 2026, Share-based Compensation rose 5.56% year-over-year to $23.0 million; the TTM value through Mar 2026 reached $85.7 million, up 22.56%, while the annual FY2025 figure was $84.5 million, 37.73% up from the prior year.
  • Share-based Compensation hit $23.0 million in Q1 2026 for Corcept Therapeutics, up from $20.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $23.0 million in Q1 2026 and bottomed at $10.5 million in Q4 2022.
  • Average Share-based Compensation over 5 years is $15.3 million, with a median of $13.2 million recorded in 2024.
  • Year-over-year, Share-based Compensation fell 4.17% in 2022 and then soared 64.77% in 2025.
  • Corcept Therapeutics' Share-based Compensation stood at $10.5 million in 2022, then increased by 24.18% to $13.1 million in 2023, then rose by 28.56% to $16.8 million in 2024, then grew by 23.65% to $20.8 million in 2025, then increased by 10.95% to $23.0 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $23.0 million, $20.8 million, and $22.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.